Published in Diabetes Care on May 01, 2004
Clinical guideline: management of gastroparesis. Am J Gastroenterol (2012) 3.86
High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg (2009) 1.40
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci (2007) 1.28
Gastroparesis: current diagnostic challenges and management considerations. World J Gastroenterol (2009) 1.16
Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations. Dig Dis Sci (2005) 0.99
Treatment of patients with diabetic gastroparesis. Gastroenterol Hepatol (N Y) (2010) 0.95
Gastroparesis: concepts, controversies, and challenges. Scientifica (Cairo) (2012) 0.95
Efficacy of gastric electrical stimulation in improving functional vomiting in patients with normal gastric emptying. Dig Dis Sci (2009) 0.93
Two-channel gastric pacing with a novel implantable gastric pacemaker accelerates glucagon-induced delayed gastric emptying in dogs. Am J Surg (2008) 0.92
New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol (2013) 0.92
Treatment options for patients with severe gastroparesis. Gut (2007) 0.89
Review article: gastric electrical stimulation for gastroparesis--physiological foundations, technical aspects and clinical implications. Aliment Pharmacol Ther (2009) 0.88
Management of diabetic gastroparesis. Saudi J Gastroenterol (2011) 0.87
Minimally invasive surgical approach for the treatment of gastroparesis. Surg Endosc (2012) 0.84
Gastric electrical stimulation for gastroparesis. J Neurogastroenterol Motil (2012) 0.84
Transcutaneous electrical nerve stimulation (TENS) improves the diabetic cytopathy (DCP) via up-regulation of CGRP and cAMP. PLoS One (2013) 0.83
Cisplatin-induced gastric dysrhythmia and emesis in dogs and possible role of gastric electrical stimulation. Dig Dis Sci (2008) 0.83
Pyloric injection of botulinum toxin for the treatment of refractory GERD accompanied with gastroparesis: a preliminary report. Dig Dis Sci (2008) 0.82
Synchronized gastric electrical stimulation improves vagotomy-induced impairment in gastric accommodation via the nitrergic pathway in dogs. Am J Physiol Gastrointest Liver Physiol (2008) 0.81
Preoperative predictors of significant symptomatic response after 1 year of gastric electrical stimulation for gastroparesis. World J Surg (2010) 0.81
Effects of dual pulse gastric electrical stimulation on gastric tone and compliance in dogs. Dig Liver Dis (2008) 0.80
Gastroparesis: current concepts and management. Gut Liver (2009) 0.79
Gastric electrical stimulation decreases gastric distension-induced central nociception response through direct action on primary afferents. PLoS One (2012) 0.78
Gastric electrical stimulation for refractory gastroparesis: predictors of response and redefining a successful outcome. Am Surg (2015) 0.77
Gastric electrical stimulation: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.76
Temporary gastric neuromodulation for intractable nausea and vomiting. Ann R Coll Surg Engl (2011) 0.76
Gastric Electrical Stimulation with the Enterra System: A Systematic Review. Gastroenterol Res Pract (2015) 0.76
Gastric electrical stimulation significantly increases canine lower esophageal sphincter pressure. Dig Dis Sci (2005) 0.76
Neuroenteric Stimulation for Gastroparesis. Curr Treat Options Gastroenterol (2015) 0.76
Synchronized dual pulse gastric electrical stimulation induces activation of enteric glial cells in rats with diabetic gastroparesis. Gastroenterol Res Pract (2014) 0.75
Prospective evaluation of gastric neurostimulation for diabetic gastroparesis in Canada. Can J Gastroenterol Hepatol (2015) 0.75
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol (2007) 3.65
Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology (2010) 2.30
Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol (2007) 2.18
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol (2008) 1.90
Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg (2005) 1.90
Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol (2011) 1.88
Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol (2009) 1.73
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos (2003) 1.66
Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol (2009) 1.54
Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med (2003) 1.37
Crohn's disease and the mycobacterioses: a quarter century later. Causation or simple association? Crit Rev Microbiol (2012) 1.33
Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol (2010) 1.27
Measurement of gastrointestinal transit. Dig Dis Sci (2005) 1.20
Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two-year follow-up study. J Clin Gastroenterol (2010) 1.08
Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg (2003) 1.08
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. Am J Med Sci (2007) 1.07
Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis. Clin Gastroenterol Hepatol (2005) 1.06
Treatment of high-frequency gastric electrical stimulation for gastroparesis. J Gastroenterol Hepatol (2012) 1.05
Treatment of gastroparesis with electrical stimulation. Dig Dis Sci (2003) 1.04
Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol (2009) 1.03
Dumping syndrome: establishing criteria for diagnosis and identifying new etiologies. Dig Dis Sci (2010) 1.01
Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations. Dig Dis Sci (2005) 0.99
Fructose intake at current levels in the United States may cause gastrointestinal distress in normal adults. J Am Diet Assoc (2005) 0.97
Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci (2008) 0.97
Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology (2011) 0.96
Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use. Ther Adv Chronic Dis (2013) 0.95
Optimizing the diagnostic power with gastric emptying scintigraphy at multiple time points. BMC Med Res Methodol (2011) 0.95
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol (2010) 0.94
Efficacy of gastric electrical stimulation in improving functional vomiting in patients with normal gastric emptying. Dig Dis Sci (2009) 0.93
Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting. Am J Med Sci (2015) 0.92
Two-channel gastric pacing with a novel implantable gastric pacemaker accelerates glucagon-induced delayed gastric emptying in dogs. Am J Surg (2008) 0.92
Disturbances of esophageal motility in eosinophilic esophagitis: a case series. Dysphagia (2009) 0.91
Cholecystectomy and clinical presentations of gastroparesis. Dig Dis Sci (2013) 0.89
Gastroparesis, pseudoachalasia and impaired intestinal motility as paraneoplastic manifestations of small cell lung cancer. Am J Med Sci (2009) 0.89
Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention. Am J Physiol Gastrointest Liver Physiol (2008) 0.88
Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease. Am J Med Sci (2015) 0.88
Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol (2010) 0.87
Gastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesis. Neuromodulation (2012) 0.87
Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking. Hepatology (2011) 0.87
Gastrointestinal electrical stimulation for treatment of gastrointestinal disorders: gastroparesis, obesity, fecal incontinence, and constipation. Gastroenterol Clin North Am (2007) 0.86
Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus. Ann N Y Acad Sci (2013) 0.86
Crohn's disease may be differentiated into 2 distinct biotypes based on the detection of bacterial genomic sequences and virulence genes within submucosal tissues. J Clin Gastroenterol (2013) 0.86
Cyclic vomiting syndrome: treatment options. Exp Brain Res (2014) 0.86
Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis. Am J Med Sci (2009) 0.85
Gastroparesis secondary to a demyelinating disease: a case series. BMC Gastroenterol (2007) 0.84
Treatment of refractory gastroparesis: gastric and jejunal tubes, botox, gastric electrical stimulation, and surgery. Gastrointest Endosc Clin N Am (2009) 0.83
Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations. Am J Med Sci (2004) 0.81
Two-channel gastric pacing in patients with diabetic gastroparesis. Neurogastroenterol Motil (2011) 0.81
Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. J Reprod Med (2005) 0.81
Comparison of anorectal manometry to endoanal ultrasound in the evaluation of fecal incontinence. Am J Med Sci (2009) 0.80
Chronic gastritis is not associated with gastric dysrhythmia or delayed solid emptying in children with dyspepsia. Dig Dis Sci (2005) 0.80
Electrogastrography in pediatric functional dyspepsia: relationship to gastric emptying and symptom severity. J Pediatr Gastroenterol Nutr (2006) 0.80
Elevated serum ghrelin levels in adult patients with cyclic vomiting syndrome. Am J Gastroenterol (2011) 0.79
Mechanisms of high-frequency electrical stimulation of the stomach in gastroparetic patients. Conf Proc IEEE Eng Med Biol Soc (2006) 0.79
Pharmacotherapy of gastroparesis. Expert Opin Pharmacother (2009) 0.79
Gastrointestinal autonomic nerve tumor secreting catecholamines. Virchows Arch (2005) 0.78
Prokinetics in diabetic gastroparesis. Curr Gastroenterol Rep (2012) 0.78
Robust propagation velocity estimation of gastric electrical activity by least mean p-norm blind channel identification. Med Biol Eng Comput (2007) 0.78
The effect of a meal and water loading on heart rate variability in children with functional dyspepsia. Dig Dis Sci (2009) 0.78
Protein expression profiling of nuclear membrane protein reveals potential biomarker of human hepatocellular carcinoma. Clin Proteomics (2013) 0.78
Evaluation of acotiamide for the treatment of functional dyspepsia. Expert Opin Drug Metab Toxicol (2014) 0.77
Barrett's esophagus: clinical features, obesity, and imaging. Ann N Y Acad Sci (2011) 0.77
Gastric juice prostaglandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study. Dig Dis Sci (2011) 0.76
EUS guidance in gastric pacemaker implantation. Gastrointest Endosc (2002) 0.76
Barrett's esophagus: surgical treatments. Ann N Y Acad Sci (2011) 0.76
Multicenter, double-blind, placebo-controlled crossover study to assess the acute prokinetic efficacy of nizatidine-controlled release (150 and 300 mg) in patients with gastroesophageal reflux disease. Am J Med Sci (2010) 0.75
An evaluation of adult electrogastrography criteria in healthy children. Dig Dis Sci (2006) 0.75
Chronic vomiting and diarrhea in a young adult female. Am J Case Rep (2013) 0.75
Association of marijuana use and cyclic vomiting syndrome. Pharmaceuticals (Basel) (2012) 0.75
Severe gastroparesis: medical therapy or gastric electrical stimulation. Clin Gastroenterol Hepatol (2009) 0.75
Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect. Clin Gastroenterol Hepatol (2007) 0.75
The treatment of gastroparesis in the age of the gastric pacemaker: a review. MedGenMed (2003) 0.75
Mesenteric venulitis: a rare etiology of hematochezia and "colitis" with distinctive colon pathology. Dig Dis Sci (2007) 0.75
Does grading the severity of gastroparesis based on scintigraphic gastric emptying predict the treatment outcome of patients with gastroparesis? Dig Dis Sci (2010) 0.75
Estimation of propagation velocity of gastric electrical activity using LMSTDE. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Frequency of Jackhammer Esophagus as the Extreme Phenotypes of Esophageal Hypercontractility Based on the New Chicago Classification. J Clin Gastroenterol (2016) 0.75